BIOCELTIX S.A. ZY -10 (F:XI3) — Stock Price
BIOCELTIX S.A. ZY -10 (F:XI3) is currently trading at €20.40 EUR, up 6.36% today. Over the past 52 weeks, shares have ranged between €14.08 and €28.60. This page tracks BIOCELTIX S.A. ZY -10's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is BIOCELTIX S.A. ZY -10 worth.
BIOCELTIX S.A. ZY -10 (XI3) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BIOCELTIX S.A. ZY -10's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
BIOCELTIX S.A. ZY -10 Income Statement — Revenue, Profit & Earnings by Year
BIOCELTIX S.A. ZY -10's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Cost of Revenue | €2.04 Million | €1.43 Million | €1.04 Million | €699.99K | €853.86K |
| Gross Profit | €-2.04 Million | €-1.43 Million | €-1.04 Million | €-699.99K | €-853.86K |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | €9.43 Million | €5.21 Million | €2.94 Million |
| Total Operating Expenses | €15.16 Million | €14.72 Million | €14.02 Million | €8.95 Million | €4.40 Million |
| Operating Income | €-15.16 Million | €-14.72 Million | €-14.02 Million | €-8.95 Million | €-4.40 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €150.40K | €169.07K | €33.65K | €31.51K | €22.95K |
| Income Before Tax | €-15.17 Million | €-14.51 Million | €-13.69 Million | €-8.97 Million | €-4.36 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-15.16 Million | €-14.54 Million | €-13.69 Million | €-8.92 Million | €-4.40 Million |
BIOCELTIX S.A. ZY -10 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BIOCELTIX S.A. ZY -10's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €75.63 Million | €41.85 Million | €12.74 Million | €7.65 Million | €8.20 Million |
| Total Current Assets | €71.29 Million | €39.42 Million | €11.21 Million | €4.36 Million | €6.51 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | €0.00 | €133.50 | €465.40 | €169.60 | €0.00 |
| Inventory | €0.00 | €14.00K | €8.62K | €0.00 | €0.00 |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Total Liabilities | €2.36 Million | €3.44 Million | €2.27 Million | €2.50 Million | €2.20 Million |
| Total Current Liabilities | €2.19 Million | €3.20 Million | €2.14 Million | €2.25 Million | €1.91 Million |
| Long-term Debt | — | — | — | — | €0.00 |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €73.28 Million | €38.42 Million | €10.47 Million | €5.15 Million | €6.00 Million |
| Retained Earnings | €-14.80 Million | €-14.90 Million | €-13.74 Million | €-13.99 Million | €-9.47 Million |
BIOCELTIX S.A. ZY -10 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BIOCELTIX S.A. ZY -10 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-11.95 Million | €-17.57 Million | €-14.75 Million | €-7.87 Million | €-4.02 Million |
| Capital Expenditures | €1.97 Million | €242.78K | €458.35K | €351.73K | €5.98K |
| Free Cash Flow | €-13.92 Million | €-17.81 Million | €-15.21 Million | €-8.23 Million | €-4.02 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €680.06K | €574.44K | €434.80K | €445.39K | €376.98K |
| Change in Cash | €34.77 Million | €24.32 Million | €5.19 Million | €-1.93 Million | €2.85 Million |
BIOCELTIX S.A. ZY -10 Earnings History — EPS Actual vs. Analyst Estimates
Track BIOCELTIX S.A. ZY -10's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for BIOCELTIX S.A. ZY -10.